Rayacryl hydrophilic IOLs are equally effective in preventing PCO as hydrophobic lenses, rotationally stable, decentration resistant, highly biocompatible and glistening free.
Over 12.5 million Rayacryl lenses sold since first launched.
RayOne Hydrophobic and RayOne Aspheric show no statistically significant difference for PCO at 12 months.
In a prospective study in 66 eyes the RayOne platform showed a high level of rotational stability and centration 3 to 6 months after surgery.
Excellent biocompatibility – low rate of uveal and capsule complications.
